XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-based Compensation Expense

Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company’s stock-based awards, was as follows:

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2021

 

 

2020

 

 

 

(in thousands)

 

Cost of revenue

 

$

397

 

 

$

58

 

Selling and marketing

 

 

331

 

 

 

199

 

Research and development

 

 

249

 

 

 

125

 

General and administrative

 

 

809

 

 

 

617

 

Total stock-based compensation

 

$

1,786

 

 

$

999

 

Stock Activity and Total Number of Shares Available for Grant

The following table presents the stock activity and the total number of shares available for grant as of March 31, 2021:

 

 

(in thousands)

 

Balance at December 31, 2020

 

 

501

 

Options granted

 

 

(12

)

Options cancelled

 

 

6

 

Restricted stock granted

 

 

(88

)

Forfeited/Expired restricted stock added back

 

 

2

 

Balance at March 31, 2021

 

 

409

 

 

Stock Option Activity

 

 

 

Options Outstanding

 

 

 

Number of

Shares

Underlying

Outstanding

Options

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

 

Outstanding at December 31, 2020

 

 

2,383,427

 

 

$

7.85

 

 

$

7.78

 

 

$

33,064,942

 

Granted

 

 

11,550

 

 

 

27.20

 

 

 

 

 

 

 

 

 

Exercised

 

 

(158,544

)

 

 

5.75

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(5,884

)

 

 

12.04

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2021

 

 

2,230,549

 

 

$

8.09

 

 

 

7.76

 

 

$

41,454,353

 

Vested and expected to vest at March 31, 2021

 

 

2,174,246

 

 

$

8.11

 

 

 

7.74

 

 

$

40,498,749

 

Exercisable at March 31, 2021

 

 

855,796

 

 

$

7.74

 

 

 

6.44

 

 

$

16,289,457

 

 

Schedule of Weighted-Average Assumptions The following are the assumptions for options granted during the three months ended March 31, 2021

 

Expected term (in years)

 

 

6.1

 

Risk-free interest rate

 

0.5%- 1.1%

 

Expected volatility

 

59.6%- 59.8%

 

Dividend rate

 

0%

 

 

Restricted stock awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Restricted Stock Activity

 

 

 

Shares

 

 

Weighted

Average

Grant Date

Fair Value

Per Share

 

Nonvested restricted stock at December 31, 2020

 

 

677,590

 

 

$

9.71

 

Granted

 

 

87,746

 

 

 

21.60

 

Vested

 

 

(20,143

)

 

 

22.90

 

Shares forfeited

 

 

(2,139

)

 

 

12.14

 

Nonvested restricted stock at March 31, 2021

 

 

743,054

 

 

$

10.75